Market Cap 373.30B
Revenue (ttm) 61.16B
Net Income (ttm) 4.23B
EPS (ttm) N/A
PE Ratio 20.72
Forward PE 14.20
Profit Margin 6.91%
Debt to Equity Ratio -20.91
Volume 5,654,000
Avg Vol 7,327,532
Day's Range N/A - N/A
Shares Out 1.77B
Stochastic %K 35%
Beta 0.34
Analysts Strong Sell
Price Target $249.82

Company Profile

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung cancer. It also provides...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 847 932 7900
Address:
1 North Waukegan Road, North Chicago, United States
Creator_SPY
Creator_SPY Mar. 28 at 11:41 AM
$ABBV no clean bias
0 · Reply
UsingAGodAlgorithm
UsingAGodAlgorithm Mar. 28 at 6:20 AM
$SE (-75% from short entry) We are the best on ST as far as we have seen. Check our profile We also covered these names. $ABBV $PLTR $MU $MA
0 · Reply
middleman
middleman Mar. 27 at 8:05 PM
$ABBV hung tough today
1 · Reply
Joselyn
Joselyn Mar. 27 at 7:24 PM
$ABBV under HOD, stair stepping up
0 · Reply
Guntz
Guntz Mar. 27 at 7:07 PM
$ABBV Fought valiantly but last hour will be difficult to buck the trend
0 · Reply
Piton_7
Piton_7 Mar. 27 at 6:14 PM
$ABBV vs 7.71M average, liquidity supportive
0 · Reply
Guntz
Guntz Mar. 27 at 5:24 PM
0 · Reply
GrapeGatsby
GrapeGatsby Mar. 27 at 4:34 PM
$ABBV Will exit my position and lock in gains if it looks like it's closing under 210.
1 · Reply
Guntz
Guntz Mar. 27 at 4:03 PM
$ABBV Well fun while it lasted lol
0 · Reply
67X_ROI_Q1_2026
67X_ROI_Q1_2026 Mar. 27 at 3:26 PM
$SLS the Market Cap, Market Value of SLS is up 1,600% in the last year since the IDMC Unblinded Actual Phase 3 Median Overall Survival and Immune Response Data - that told, everyone paying attention, GPS is 100% for Sure Getting Fda Approval - GUARANTEED. $ABBV $RHHBY and $BMY who own Aza and VEN - Know Precisely how their drugs work for AML Remission patients, they know GPS is the only reason we are and have been seeing Miraculous All Pooled Survival Data.
0 · Reply
Latest News on ABBV
AbbVie: Strong 2026 Outlook, Expect Dividend Increases

Mar 27, 2026, 2:42 PM EDT - 23 hours ago

AbbVie: Strong 2026 Outlook, Expect Dividend Increases


Buy Or Fear AbbVie Stock At $210?

Mar 19, 2026, 9:26 AM EDT - 9 days ago

Buy Or Fear AbbVie Stock At $210?


Best Dividend Kings: March 2026

Mar 19, 2026, 3:27 AM EDT - 9 days ago

Best Dividend Kings: March 2026

ABM ABT ADM ADP AWR BDX BKH


Harbor Health Care ETF Q4 2025 Portfolio Review

Mar 11, 2026, 8:18 AM EDT - 17 days ago

Harbor Health Care ETF Q4 2025 Portfolio Review

ABVX GMAB LLY MASI MEDI MRK RVMD


February Dividends With 4 Raises: 1.6% Up To 14.5%

Mar 3, 2026, 8:14 AM EST - 25 days ago

February Dividends With 4 Raises: 1.6% Up To 14.5%

BMY BTI MA


Best Dividend Aristocrats For March 2026

Feb 27, 2026, 12:21 PM EST - 4 weeks ago

Best Dividend Aristocrats For March 2026

ABT ADM ADP AFL ALB AMCR AOS


AbbVie Declares Quarterly Dividend

Feb 19, 2026, 9:37 AM EST - 5 weeks ago

AbbVie Declares Quarterly Dividend


AbbVie: Dominating Immunology While Building Oncology Upside

Feb 17, 2026, 1:11 AM EST - 5 weeks ago

AbbVie: Dominating Immunology While Building Oncology Upside


AbbVie sues US health agency over Botox price controls

Feb 11, 2026, 6:49 PM EST - 6 weeks ago

AbbVie sues US health agency over Botox price controls


Abbvie sues US health agency over Botox

Feb 11, 2026, 5:13 PM EST - 6 weeks ago

Abbvie sues US health agency over Botox


2 Urgent Sells And 2 No Brainer Dividend Buys

Feb 11, 2026, 4:06 PM EST - 6 weeks ago

2 Urgent Sells And 2 No Brainer Dividend Buys

AEP AMGN BMY ESS HASI HD PFE


Dividend Kings: No Ideal Buys In February's 57

Feb 10, 2026, 9:45 AM EST - 6 weeks ago

Dividend Kings: No Ideal Buys In February's 57

ABM ADP CWT FRT FTS HRL HTO


AbbVie: The Market Is Getting It Wrong

Feb 5, 2026, 8:52 AM EST - 7 weeks ago

AbbVie: The Market Is Getting It Wrong


AbbVie Inc. (ABBV) Q4 2025 Earnings Call Transcript

Feb 4, 2026, 1:20 PM EST - 7 weeks ago

AbbVie Inc. (ABBV) Q4 2025 Earnings Call Transcript


AbbVie Revenue Rises on Immunology Growth

Feb 4, 2026, 8:34 AM EST - 7 weeks ago

AbbVie Revenue Rises on Immunology Growth


Creator_SPY
Creator_SPY Mar. 28 at 11:41 AM
$ABBV no clean bias
0 · Reply
UsingAGodAlgorithm
UsingAGodAlgorithm Mar. 28 at 6:20 AM
$SE (-75% from short entry) We are the best on ST as far as we have seen. Check our profile We also covered these names. $ABBV $PLTR $MU $MA
0 · Reply
middleman
middleman Mar. 27 at 8:05 PM
$ABBV hung tough today
1 · Reply
Joselyn
Joselyn Mar. 27 at 7:24 PM
$ABBV under HOD, stair stepping up
0 · Reply
Guntz
Guntz Mar. 27 at 7:07 PM
$ABBV Fought valiantly but last hour will be difficult to buck the trend
0 · Reply
Piton_7
Piton_7 Mar. 27 at 6:14 PM
$ABBV vs 7.71M average, liquidity supportive
0 · Reply
Guntz
Guntz Mar. 27 at 5:24 PM
0 · Reply
GrapeGatsby
GrapeGatsby Mar. 27 at 4:34 PM
$ABBV Will exit my position and lock in gains if it looks like it's closing under 210.
1 · Reply
Guntz
Guntz Mar. 27 at 4:03 PM
$ABBV Well fun while it lasted lol
0 · Reply
67X_ROI_Q1_2026
67X_ROI_Q1_2026 Mar. 27 at 3:26 PM
$SLS the Market Cap, Market Value of SLS is up 1,600% in the last year since the IDMC Unblinded Actual Phase 3 Median Overall Survival and Immune Response Data - that told, everyone paying attention, GPS is 100% for Sure Getting Fda Approval - GUARANTEED. $ABBV $RHHBY and $BMY who own Aza and VEN - Know Precisely how their drugs work for AML Remission patients, they know GPS is the only reason we are and have been seeing Miraculous All Pooled Survival Data.
0 · Reply
Th3rston
Th3rston Mar. 27 at 3:14 PM
Can someone please let $ABBV know that the market's in a correction?
1 · Reply
Guntz
Guntz Mar. 27 at 2:12 PM
$ABBV It will be a battle here. Heavy supply zone
0 · Reply
Whiskeyunderthebed
Whiskeyunderthebed Mar. 27 at 1:52 PM
$ABBV $204 was a good buy...
0 · Reply
middleman
middleman Mar. 27 at 1:00 PM
$ABBV lets go abbvie hang in there!
0 · Reply
NasdaqPulse
NasdaqPulse Mar. 27 at 11:36 AM
$ABBV income hunters, listen up Chasing $10,000/year in passive dividends? At today’s payout, that means roughly ~1.7K–2K shares depending on your cost basis and entry point. That’s the power of a steady dividend grower like AbbVie—cash flow you don’t have to “time the market” for. But here’s the catch Dividend safety matters Payout ratio + growth = long-term sustainability Reinvesting can dramatically lower your required share count over time This isn’t just about hitting $10K—it’s about compounding toward financial freedom. Do your own due diligence. Dividends are not guaranteed and can change.
0 · Reply
Tomrph
Tomrph Mar. 27 at 11:27 AM
$ABBV money moving to healthcare now? ABBV…lead the way
1 · Reply
67X_ROI_Q1_2026
67X_ROI_Q1_2026 Mar. 27 at 5:18 AM
$SLS $ABBV for the short bus riders, AZA+Ven, BAT, the Best Available Treatment for Control Patients in the SLS Phase 3 REGAL trial, recently FAILED 3 Large Phase 3 trials conducted by $ABBV, including Failing 2 for AML Remission Maintenance. it’s not at all complicated.
0 · Reply
Maxwell_Osgood
Maxwell_Osgood Mar. 27 at 1:50 AM
$ABBV helpful little bounce today...
0 · Reply
67X_ROI_Q1_2026
67X_ROI_Q1_2026 Mar. 27 at 1:11 AM
$SLS $ABBV Again, for the record, there are NO AML CR2 Patients Surviving at 24 months, absent transplant - in any published trial data any where ... this would include EVERY REGAL Eligible Patient, the Youngest and the So Called Healthiest and the MRD - ALL of them - and there is NIL survival at 24 months ... All 128 P3 Patients - 64 Control ARM on BAT - were enrolled 24 months ago. . . and there is NIL Survival even allowing for a small handful of Super Rare Outliers =/+/- 60 EVENTS and we AWAIT 80 ... BAT for Control is AZA +VEN, Aza+VEN Failed 3 Large Phase 3 Trials - including 2 for AML Remission Maintenance. HELLO??? it's not at all complicated.
0 · Reply
67X_ROI_Q1_2026
67X_ROI_Q1_2026 Mar. 27 at 12:41 AM
$SLS $ABBV AMONG ALL These BEGGING SHORT LOWLIFE - not 1 Can Answer... -- FIND 1 Trial where AML Cr2 Patients on BAT, are surviving at ALL at 24 months, absent transplant ... GO AHEAD LOWLIFE FIND 1.... ... You won't because YOU SHORT LOWLIFE LIARS CAN'T its been 24 months since enrollment completed 128 Patients - 64 Control Patients and there are Nil Survivors. Except a Rare Outlier =/+/- 60 EVENTS Just from the Control Arm While We Await 80 . . Gps Arm =+/- 19 / 20 ANY DAY NOW
1 · Reply
Guntz
Guntz Mar. 26 at 9:20 PM
$ABBV $215 is the 200ma. Would be amazing if we can test that tomorrow. Maybe wishful thinking but one can hope lol
1 · Reply
Stockman824
Stockman824 Mar. 26 at 8:17 PM
$ABBV $LLY $NVO $VKTX SOMETHING is LEAKING
0 · Reply